| Date Filed | Type | Description |
| 08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
8-K
| Quarterly results |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/07/2023 |
4
| FINNEY ELISHA W (Director) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Sold 194 shares
@ $190.41, valued at
$36.9k
|
|
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/18/2023 |
4
| Sanzone Virginia Ruth (VP, General Counsel) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Granted 4,872 options to buy
@ $0 |
|
| 05/18/2023 |
4
| Bonnell Brian Michael (CFO) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Granted 9,743 options to buy
@ $0 |
|
| 05/18/2023 |
4
| Voigtlander Christian B. (COO) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Granted 9,743 options to buy
@ $0 |
|
| 05/18/2023 |
4
| Jain Vivek (Chairman and CEO) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Granted 14,615 options to buy
@ $0 |
|
| 05/18/2023 |
4
| KENNEDY KOLLEEN T (Director) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Exercised 485 options to buy
@ $0
Granted 948 options to buy
@ $0 |
|
| 05/18/2023 |
4
| Hoffmeister David F (Director) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Exercised 485 options to buy
@ $0
Granted 948 options to buy
@ $0 |
|
| 05/18/2023 |
4
| FINNEY ELISHA W (Director) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Exercised 485 options to buy
@ $0
Granted 948 options to buy
@ $0 |
|
| 05/18/2023 |
4
| Abbey Donald (Director) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Exercised 485 options to buy
@ $0
Granted 948 options to buy
@ $0 |
|
| 05/18/2023 |
4
| Hernandez Laurie (Director) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Exercised 485 options to buy
@ $0
Granted 948 options to buy
@ $0 |
|
| 05/18/2023 |
4
| Greenberg David C. (Director) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Exercised 485 options to buy
@ $0
Granted 948 options to buy
@ $0 |
|
| 05/08/2023 |
8-K
| Quarterly results |
| 04/05/2023 |
4
| Sanzone Virginia Ruth (VP, General Counsel) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Sold 458 shares
@ $170, valued at
$77.9k
|
|
| 04/04/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/04/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/04/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/15/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/08/2023 |
4
| Woolson Daniel (VP, GM-Infusion Capital) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Paid exercise price by delivering 626 shares
@ $161.25, valued at
$100.9k
Paid exercise price by delivering 428 shares
@ $157.47, valued at
$67.4k
Paid exercise price by delivering 894 shares
@ $156.17, valued at
$139.6k
Exercised 965 options to buy
@ $0
Exercised 2,020 options to buy
@ $0
Exercised 1,417 options to buy
@ $0 |
|
| 03/08/2023 |
4
| Sanzone Virginia Ruth (VP, General Counsel) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Paid exercise price by delivering 839 shares
@ $161.25, valued at
$135.3k
Paid exercise price by delivering 564 shares
@ $157.47, valued at
$88.8k
Paid exercise price by delivering 1,196 shares
@ $156.17, valued at
$186.8k
Exercised 1,072 options to buy
@ $0
Exercised 2,272 options to buy
@ $0
Exercised 1,595 options to buy
@ $0 |
|
| 03/08/2023 |
4
| Voigtlander Christian B. (COO) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Paid exercise price by delivering 4,604 shares
@ $161.25, valued at
$742.4k
Paid exercise price by delivering 816 shares
@ $161.25, valued at
$131.6k
Paid exercise price by delivering 1,129 shares
@ $157.47, valued at
$177.8k
Paid exercise price by delivering 1,163 shares
@ $156.17, valued at
$181.6k
Exercised 1,551 options to buy
@ $0
Exercised 2,209 options to buy
@ $0
Exercised 2,145 options to buy
@ $0
Exercised 8,745 options to buy
@ $0 |
|
| 03/08/2023 |
4
| Jain Vivek (Chairman and CEO) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Paid exercise price by delivering 933 shares
@ $161.25, valued at
$150.4k
Paid exercise price by delivering 5,261 shares
@ $161.25, valued at
$848.3k
Paid exercise price by delivering 1,694 shares
@ $157.47, valued at
$266.8k
Paid exercise price by delivering 1,329 shares
@ $156.17, valued at
$207.5k
Exercised 1,773 options to buy
@ $0
Exercised 2,525 options to buy
@ $0
Exercised 3,218 options to buy
@ $0
Exercised 9,994 options to buy
@ $0 |
|
| 03/08/2023 |
4
| Bonnell Brian Michael (CFO) has filed a Form 4 on ICU MEDICAL INC/DE|
Txns:
| Paid exercise price by delivering 816 shares
@ $161.25, valued at
$131.6k
Paid exercise price by delivering 4,604 shares
@ $161.25, valued at
$742.4k
Paid exercise price by delivering 1,129 shares
@ $157.47, valued at
$177.8k
Paid exercise price by delivering 1,163 shares
@ $156.17, valued at
$181.6k
Exercised 1,551 options to buy
@ $0
Exercised 2,209 options to buy
@ $0
Exercised 2,145 options to buy
@ $0
Exercised 8,745 options to buy
@ $0 |
|
| 02/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/27/2023 |
8-K
| Quarterly results |
| 02/14/2023 |
SC 13G/A
| T. Rowe Price Investment Management, Inc. reports a 10.1% stake in ICU MEDICAL INC |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.8% stake in ICU Medical Inc. |
| 02/06/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|